In intrahepatic cholangiocarcinoma (iCCA), ADAR1 enhances carcinogenic signals by mediating RNA editing of KPC1, which reduces the binding affinity of NF-κB1 p105 [395]. This evidence concerns the gene NFKB1 and infantile convulsions and choreoathetosis.